Add BrightSurf on Google Email

Changes Upstream: RIPE team uses CRISPR/Cas9 to alter photosynthesis for the first time

Researchers from the University of Illinois have used CRISPR/Cas9 to alter the upstream regulatory DNA of a food crop, increasing gene expression and improving downstream photosynthesis. This approach, which does not require adding foreign DNA, has shown promising results in increasing photosynthetic activity in rice.

Association of mosaic chromosomal alterations and genetic factors with the risk of cirrhosis

This study investigates the association of mosaic chromosomal alterations (mCAs) with cirrhosis risk and finds that individuals with copy-neutral loss of heterozygosity mCAs have a significantly increased risk of cirrhosis. The risk is higher in patients with expanded cell fractions of mCAs, especially for decompensated cirrhosis.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateMay 30, 2024

Researchers expose new symbiosis origin theories, identify experimental systems for plant life

Researchers challenge single-origin theory of root nodule symbiosis, identifying multiple origins and ideal experimental systems to better understand symbiotic relationships. The findings suggest a lesser role for shared genetic machinery in genetically engineering crop plants to work with nitrogen-fixing bacteria.

SourceMississippi State University·JournalNature Communications·TypeComputational simulation/modeling·DateMay 29, 2024

Gentler cell therapies for blood cancer

Researchers have developed an approach to 'delete' a diseased blood system while building up a new, healthy one with donor blood stem cells. This process involves targeting specific antibodies coupled to a cytotoxic drug that recognize and destroy diseased blood cells while sparing healthy ones.

SourceUniversity of Basel·JournalNature·TypeExperimental study·DateMay 22, 2024

New resource pinpoints inner workings of sorghum plant cells

A new resource has been created to provide a deeper understanding of the bioenergy crop sorghum and its potential for genetic modification. The study identified gene expression patterns in sorghum stem cells, which can help researchers design cell-type specific promoters for targeted gene expression.

Study suggests high-frequency electrical ‘noise’ results in congenital night blindness

Researchers at Johns Hopkins Medicine used genetically engineered mice to study the mechanism of congenital stationary night blindness. The findings demonstrate that a mutation in the rhodopsin gene produces unusual background electrical activity, desensitizing rods and causing poor vision in low-light settings.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateMay 16, 2024

SMART breakthrough research identifies mechanism behind drug resistance in malaria parasite

A recent study reveals that a cellular process called transfer Ribonucleic acid (tRNA) modification influences the malaria parasite’s ability to develop resistance. This breakthrough discovery could help researchers develop new drugs to combat resistance and better tools for studying RNA modifications.

SourceSingapore-MIT Alliance for Research and Technology (SMART)·JournalNature Microbiology·TypeExperimental study·DateMay 16, 2024

Biofortified rice to combat deficiencies

Researchers at UNIGE and ETH Zurich have created biofortified rice lines with enhanced vitamin B1 content, targeting the nourishing tissue of the grain. The modified lines multiplied vitamin B1 levels by 3-4 without compromising agronomic yield, providing a significant advance in combating deficiency.

SourceUniversité de Genève·JournalPlant Biotechnology Journal·TypeNews article·DateApr 11, 2024

Chinese Medical Journal Review highlights novel pathogenic mechanisms and therapeutic potentials in cancer treatment targeting internal N6-methyladenosine and N7-methylguanine

Researchers highlight the role of post-transcriptional RNA modifications in AML pathogenesis, identifying m6A and m7G regulators as potential therapeutic targets. Targeted therapies, including selective inhibitors and Traditional Chinese Medicine compounds, show promise in promoting cell differentiation and reversing AML phenotypes.

SourceCactus Communications·JournalChinese Medical Journal·TypeLiterature review·DateApr 10, 2024

Chinese Medical Journal article unveils metabolic strategies to enhance CAR-T cell therapy

Researchers unveil innovative strategies to overcome metabolic constraints in CAR-T cell therapy, aiming to boost its efficacy in treating solid tumors. Metabolic interventions targeting immunosuppressive metabolites, metabolite uptake, and mitochondrial metabolism are proposed to enhance anti-tumor activity.

SourceCactus Communications·JournalChinese Medical Journal·TypeSystematic review·DateMar 26, 2024

An immunotherapy to overcome resistant leukemia

Researchers have discovered a new immunotherapy approach to overcome resistant leukemia by targeting the mutated TP53 gene. Combining pharmacological therapies with genetically engineered CAR T-cells increases effectiveness against cancer cells, offering promising strategies for patients with resistant disease.

SourceUniversity of Zurich·JournalEMBO Molecular Medicine·TypeExperimental study·DateMar 21, 2024

Decoding the language of epigenetic modifications

A recent study by Helmholtz Munich scientists has made significant breakthroughs in understanding how epigenetic modifications work together to regulate the genome. The research sheds light on the complex interactions between DNA, histone proteins, and epigenetic reader proteins, providing new insights into diseases such as cancer, met...

New tool helps decipher gene behaviour

Researchers have created a new tool called epidecodeR to analyze epigenetic marks and predict their impact on gene activity. The tool can identify correlations between specific modifications and gene responses in various conditions, including cancer and neurological disorders.

SourceKyoto University·JournalBriefings in Bioinformatics·DateFeb 28, 2024

A new, comprehensive roadmap for the future of biomedical engineering

A new roadmap has been published by IEEE EMBS, outlining five primary medical challenges that need to be addressed through advanced biomedical engineering approaches. The paper, written by 50 renowned researchers from 34 prestigious universities, aims to guide future research and funding for groundbreaking innovations.

SourceUniversity of Pittsburgh·JournalIEEE Open Journal of Engineering in Medicine and Biology·TypeObservational study·DateFeb 26, 2024

New method for marking neurotransmitter receptors expressed in the living animal brain

Researchers have developed a new method to label naïve neurotransmitter receptor proteins in living animal brains without genetic manipulation. This technique, known as ligand-directed acylimidazole chemistry (LDAI chemistry), uses pulse-chase analysis to track the movement and fate of proteins in real-time.

SourceJapan Science and Technology Agency·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateFeb 22, 2024

Mapping cell behaviors in high-grade glioma to improve treatment

Researchers have identified regional biological signatures in invasive brain tumor margins of high-grade glioma, which could lead to improved diagnosis, prognosis, and treatment. Advanced MRI techniques may help distinguish between the genetic and molecular alterations, providing insights into resistance to treatment.

SourceMayo Clinic·JournalNature Communications·DateJan 30, 2024

A participant from Queen Mary University of London Genes & Health study is the 10th person enrolled in a gene-editing clinical trial for heart disease

The Genes & Health study has enrolled its 10th participant in a gene-editing clinical trial for heart disease, specifically familial hypercholesterolemia. This milestone marks an important step towards improving health outcomes for people of Pakistani and Bangladeshi descent.

SourceQueen Mary University of London·TypeRandomized controlled/clinical trial·DateNov 12, 2023

Team creates synthetic enzymes to unravel molecular mysteries

A team of researchers developed synthetic enzymes that can control the behavior of the signaling protein Vg1, which plays a key role in vertebrate embryonic development. The study uses zebrafish to investigate how Vg1 is formed and found that it must undergo additional processing before it can be activated.

SourceUniversity of Texas at Dallas·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateNov 9, 2023

‘Plug and play’ nanoparticles could make it easier to tackle various biological targets

Researchers at the University of California San Diego have created modular nanoparticles that can be tailored for various applications, including targeted drug delivery and neutralizing biological agents. By leveraging a plug-and-play approach, scientists can rapidly modify functional biological nanoparticles with ease.

SourceUniversity of California - San Diego·JournalNature Nanotechnology·DateOct 30, 2023

NUS Medicine researchers unlock the potential of genetic glycoengineering to advance vaccines and therapeutics technology

The team created a glycoengineering platform that simplifies the production of customized sugar carbohydrates, known as glycans, which play a crucial role in various therapeutic applications. This innovation enables the engineering of new glycans with unprecedented flexibility, addressing limitations in existing approaches.

SourceNational University of Singapore, Yong Loo Lin School of Medicine·JournalScience Advances·TypeRandomized controlled/clinical trial·DateOct 16, 2023

Bioengineering breakthrough increases DNA detection sensitivity by 100 times

Researchers at the University of Massachusetts Amherst have developed a new method for DNA detection that is 100 times more sensitive than traditional methods. This breakthrough enables fast and accurate disease diagnosis, reducing wait times for lab processing from days to minutes.

SourceUniversity of Massachusetts Amherst·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateOct 3, 2023

Groundbreaking research unveils genetic characteristics and improved prognosis of triple negative apocrine carcinoma

Researchers identified distinct genomic characteristics that impact prognosis for patients with triple negative apocrine carcinoma. The study confirmed a five-year disease-free survival rate of 92.2% for these patients, significantly higher than those diagnosed with other types of TNBC.